RO

Unknown

3628 clinical trials

Find Trials

Clinical Trials (3628)

Showing 20 of 3,628 trialsScroll for more
NCT04976322Phase 31 site

A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

Enrolling By Invitation
NCT06920004Phase 33 sites

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

Recruiting
NCT05711394Phase 33 sites

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Recruiting
NCT06641076Phase 36 sites

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug

Active Not Recruiting
NCT07218926Phase 34 sites

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

Recruiting
NCT03486873Phase 36 sites

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting
NCT05429632Phase 33 sites

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Recruiting
NCT06323928Phase 23 sites

A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

Completed
NCT07190248Phase 38 sites

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Recruiting
NCT05615220Phase 31 site

Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults

Completed
NCT07005128Phase 31 site

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

Recruiting
NCT06471829Phase 23 sites

A Trial of Lu AG13909 in Adult Participants With Cushing's Disease

Recruiting
NCT04728893Phase 24 sites

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

Recruiting
NCT06430801Phase 36 sites

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Recruiting
NCT06422143Phase 38 sites

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

Recruiting
NCT07091630Phase 33 sites

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

Recruiting
NCT07181109Phase 316 sites

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Recruiting

A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania

Recruiting
NCT07642037Not Applicable1 site

Marginal Biofilm Distribution and Periodontal Response to Supragingival and Juxtagingival Aligner Designs

Active Not Recruiting
NCT06072482Phase 43 sites

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Recruiting